The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils

Omar Ali El-Agnaf, Angela M. Bodles, David J S Guthrie, Patrick Harriott, G. Brent Irvine

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Examination of the N-terminal sequence of non-Aβ component of Alzheimer's Disease amyloid (NAC) revealed a degree of similarity to regions crucial for aggregation and toxicity of three other amyloidogenic proteins, namely amyloid β peptide (Aβ), prion protein (PrP) and islet amyloid polypeptide (IAPP), leading us to believe that this might be the part of the molecule responsible for causing aggregation. Secondary structure prediction analysis of NAC indicated that the N-terminal half was likely to form a β- structure whereas the C-terminal half was likely to form an α-helix. NAC in solution altered from random coil to β-sheet structure upon ageing, a process that has previously been shown to lead to fibril formation. To delineate the region of NAC responsible for aggregation we synthesised two fragments, NAC-(1-18)-peptide and NAC-(19-35)-peptide, and examined their physicochemical properties. Upon incubation, solutions of NAC-(1 - 18)- peptide became congophilic and aggregated to form fibrils of diameter 5-10 nm, whereas NAC-(19-35)-peptide did not bind Congo Red and remained in solution. Circular dichroism spectroscopy was used to study the secondary structure of NAC and the two fragments. In trifluoroethanol/water mixtures, NAC and NAC'(19-35)-peptide adopted α-helical structure but NAC(1-18)- peptide did not. NAC-(l-18)-peptide and NAC formed β-sheet in acetonitrile/water mixtures more readily than did NAC-(19-35)-peptide. CD spectra of NAC or NAC-(1-18)-peptide in aqueous solution indicate the formation of β-sheet on ageing. We propose that the N-terminal region of NAC is the principal determinant of aggregation. Our results indicate that NAC resembles Aβ, and other amyloidogenic proteins, in that aggregation is dependent upon β-sheet development. These results lend support to a role for NAC in the development of neurodegenerative disease.

Original languageEnglish
Pages (from-to)157-163
Number of pages7
JournalEuropean Journal of Biochemistry
Volume258
Issue number1
DOIs
Publication statusPublished - 15 Nov 1998
Externally publishedYes

Fingerprint

Amyloid
Alzheimer Disease
Peptides
Agglomeration
Amyloidogenic Proteins
Aging of materials
Neurodegenerative diseases
Trifluoroethanol
Circular dichroism spectroscopy
Islet Amyloid Polypeptide
Congo Red
Water
Circular Dichroism
Neurodegenerative Diseases
Toxicity
Spectrum Analysis
Molecules

Keywords

  • α synuclein
  • Alzheimer's
  • Amyloid
  • Circular dichroism
  • Non-Aβ component of Alzheimer's disease amyloid

ASJC Scopus subject areas

  • Biochemistry

Cite this

The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils. / Ali El-Agnaf, Omar; Bodles, Angela M.; Guthrie, David J S; Harriott, Patrick; Irvine, G. Brent.

In: European Journal of Biochemistry, Vol. 258, No. 1, 15.11.1998, p. 157-163.

Research output: Contribution to journalArticle

@article{d1700587545e4e068e366c1498265106,
title = "The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils",
abstract = "Examination of the N-terminal sequence of non-Aβ component of Alzheimer's Disease amyloid (NAC) revealed a degree of similarity to regions crucial for aggregation and toxicity of three other amyloidogenic proteins, namely amyloid β peptide (Aβ), prion protein (PrP) and islet amyloid polypeptide (IAPP), leading us to believe that this might be the part of the molecule responsible for causing aggregation. Secondary structure prediction analysis of NAC indicated that the N-terminal half was likely to form a β- structure whereas the C-terminal half was likely to form an α-helix. NAC in solution altered from random coil to β-sheet structure upon ageing, a process that has previously been shown to lead to fibril formation. To delineate the region of NAC responsible for aggregation we synthesised two fragments, NAC-(1-18)-peptide and NAC-(19-35)-peptide, and examined their physicochemical properties. Upon incubation, solutions of NAC-(1 - 18)- peptide became congophilic and aggregated to form fibrils of diameter 5-10 nm, whereas NAC-(19-35)-peptide did not bind Congo Red and remained in solution. Circular dichroism spectroscopy was used to study the secondary structure of NAC and the two fragments. In trifluoroethanol/water mixtures, NAC and NAC'(19-35)-peptide adopted α-helical structure but NAC(1-18)- peptide did not. NAC-(l-18)-peptide and NAC formed β-sheet in acetonitrile/water mixtures more readily than did NAC-(19-35)-peptide. CD spectra of NAC or NAC-(1-18)-peptide in aqueous solution indicate the formation of β-sheet on ageing. We propose that the N-terminal region of NAC is the principal determinant of aggregation. Our results indicate that NAC resembles Aβ, and other amyloidogenic proteins, in that aggregation is dependent upon β-sheet development. These results lend support to a role for NAC in the development of neurodegenerative disease.",
keywords = "α synuclein, Alzheimer's, Amyloid, Circular dichroism, Non-Aβ component of Alzheimer's disease amyloid",
author = "{Ali El-Agnaf}, Omar and Bodles, {Angela M.} and Guthrie, {David J S} and Patrick Harriott and Irvine, {G. Brent}",
year = "1998",
month = "11",
day = "15",
doi = "10.1046/j.1432-1327.1998.2580157.x",
language = "English",
volume = "258",
pages = "157--163",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils

AU - Ali El-Agnaf, Omar

AU - Bodles, Angela M.

AU - Guthrie, David J S

AU - Harriott, Patrick

AU - Irvine, G. Brent

PY - 1998/11/15

Y1 - 1998/11/15

N2 - Examination of the N-terminal sequence of non-Aβ component of Alzheimer's Disease amyloid (NAC) revealed a degree of similarity to regions crucial for aggregation and toxicity of three other amyloidogenic proteins, namely amyloid β peptide (Aβ), prion protein (PrP) and islet amyloid polypeptide (IAPP), leading us to believe that this might be the part of the molecule responsible for causing aggregation. Secondary structure prediction analysis of NAC indicated that the N-terminal half was likely to form a β- structure whereas the C-terminal half was likely to form an α-helix. NAC in solution altered from random coil to β-sheet structure upon ageing, a process that has previously been shown to lead to fibril formation. To delineate the region of NAC responsible for aggregation we synthesised two fragments, NAC-(1-18)-peptide and NAC-(19-35)-peptide, and examined their physicochemical properties. Upon incubation, solutions of NAC-(1 - 18)- peptide became congophilic and aggregated to form fibrils of diameter 5-10 nm, whereas NAC-(19-35)-peptide did not bind Congo Red and remained in solution. Circular dichroism spectroscopy was used to study the secondary structure of NAC and the two fragments. In trifluoroethanol/water mixtures, NAC and NAC'(19-35)-peptide adopted α-helical structure but NAC(1-18)- peptide did not. NAC-(l-18)-peptide and NAC formed β-sheet in acetonitrile/water mixtures more readily than did NAC-(19-35)-peptide. CD spectra of NAC or NAC-(1-18)-peptide in aqueous solution indicate the formation of β-sheet on ageing. We propose that the N-terminal region of NAC is the principal determinant of aggregation. Our results indicate that NAC resembles Aβ, and other amyloidogenic proteins, in that aggregation is dependent upon β-sheet development. These results lend support to a role for NAC in the development of neurodegenerative disease.

AB - Examination of the N-terminal sequence of non-Aβ component of Alzheimer's Disease amyloid (NAC) revealed a degree of similarity to regions crucial for aggregation and toxicity of three other amyloidogenic proteins, namely amyloid β peptide (Aβ), prion protein (PrP) and islet amyloid polypeptide (IAPP), leading us to believe that this might be the part of the molecule responsible for causing aggregation. Secondary structure prediction analysis of NAC indicated that the N-terminal half was likely to form a β- structure whereas the C-terminal half was likely to form an α-helix. NAC in solution altered from random coil to β-sheet structure upon ageing, a process that has previously been shown to lead to fibril formation. To delineate the region of NAC responsible for aggregation we synthesised two fragments, NAC-(1-18)-peptide and NAC-(19-35)-peptide, and examined their physicochemical properties. Upon incubation, solutions of NAC-(1 - 18)- peptide became congophilic and aggregated to form fibrils of diameter 5-10 nm, whereas NAC-(19-35)-peptide did not bind Congo Red and remained in solution. Circular dichroism spectroscopy was used to study the secondary structure of NAC and the two fragments. In trifluoroethanol/water mixtures, NAC and NAC'(19-35)-peptide adopted α-helical structure but NAC(1-18)- peptide did not. NAC-(l-18)-peptide and NAC formed β-sheet in acetonitrile/water mixtures more readily than did NAC-(19-35)-peptide. CD spectra of NAC or NAC-(1-18)-peptide in aqueous solution indicate the formation of β-sheet on ageing. We propose that the N-terminal region of NAC is the principal determinant of aggregation. Our results indicate that NAC resembles Aβ, and other amyloidogenic proteins, in that aggregation is dependent upon β-sheet development. These results lend support to a role for NAC in the development of neurodegenerative disease.

KW - α synuclein

KW - Alzheimer's

KW - Amyloid

KW - Circular dichroism

KW - Non-Aβ component of Alzheimer's disease amyloid

UR - http://www.scopus.com/inward/record.url?scp=0032533733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032533733&partnerID=8YFLogxK

U2 - 10.1046/j.1432-1327.1998.2580157.x

DO - 10.1046/j.1432-1327.1998.2580157.x

M3 - Article

C2 - 9851705

AN - SCOPUS:0032533733

VL - 258

SP - 157

EP - 163

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 1

ER -